BAFF CAR-T Cells (LMY-922) for Treatment of Refractory Autoimmune Disease
NCT07729995
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
94
Enrollment
INDUSTRY
Sponsor class
Conditions
Rheumatoid Arthritis (RA)
Systemic Lupus Erthematosus (SLE)
Dermatomyositis (DM)
Systemic Sclerosis (SSc)
Interventions
BIOLOGICAL:
LMY-922
Sponsor
Luminary Therapeutics